drugset / Trial / NCT00645515
A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the safety of ziprasidone and risperidone for the treatment of chronic schizophrenia. The primary purpose is to differentiate the effects of ziprasidone and risperidone on extrapyramidal side effects and the secondary purpose is to compare their tolerability and efficacy.
Timeline
- Start
- 2003-06
- Primary completion
- —
- Completion
- 2003-12
Outcome
Outcome not reported
Stopped (Enrollment): “This study was terminated on November 20, 2003 because of poor recruitment. This study was not terminated due to safety/efficacy.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Risperidone | Other / unclassified | 3 mg | — |
| Comparator | Risperidone | Other / unclassified | 9 mg | — |
| Subject | Ziprasidone | Small molecule | 40 mg | — |
| Subject | Ziprasidone | Small molecule | 80 mg | — |